2016-03-05T00:00:00.000-05:00
chemical entities,-0.408958
Cara Therapeutics,-0.0348566
clinical-stage biopharmaceutical company,0.374895
quarter worth,0.458168
Asset Management AG,0.361077
price objective,0.507201
Asset Management LLC,0.469623
business’s stock,-0.207885
consensus price target,0.439832
stock,0.164604
InvestorPlace Broker Center,0.555736
Therapeutics Inc Daily,0.535589
1-year high,-0.462472
research report,0.496378
biopharmaceutical company,0.422937
sell rating,0.409776
Zacks Investment Research,0.40995
personal trading style,0.598412
Allianz Asset Management,0.361077
average rating,-0.253646
Ridgeback Capital Investments,0.458168
average price,-0.221633
shares,0.207769
concise daily summary,0.54885
Asset Management L.P.,0.429823
Jennison Associates,0.397701
EverPoint Asset Management,0.469623
stock broker,0.245696
AnalystRatings.Net reports,-0.286394
Asset Management,0.420174
rating,0.225412
research analyst,0.409776
new position,0.458168
kappa opioid receptors,-0.408958
quarter,0.423279
